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ABSTRACT The amyloid beta (Ab) peptide is the major component found in the amyloid deposits in the brains of Alzheimer’s
disease patients. In vitro studies have demonstrated that the aggregation of Ab can take place at three orders of magnitude
lower concentrations in the presence of phospholipid molecules compared to bulk peptide studies, suggesting that membrane
lipids may mediate Ab toxicity. To understand the interaction of Ab with lipid membranes, we have examined Ab40 with anionic
dipalmitoylphosphatidylglycerol (DPPG), zwitterionic dipalmitoylphosphatidylcholine (DPPC), and cationic dipalmitoyltrimethyl-
ammonium propane (DPTAP) monolayers under different subphase conditions. We have used a constant surface pressure
insertion assay to assess the degree of peptide insertion into the lipids. Simultaneously, we monitored the surface morphology
of the monolayers with ﬂuorescence microscopy. We have also performed dual-probe ﬂuorescence measurements where both
the peptide and lipid are tagged with chromophores. Isotherm measurements show that Ab inserts into both DPTAP and DPPG
monolayers under physiologically relevant conditions. Insertion into DPPC occurs at lipid densities below that found in a bilayer.
The level of insertion is inversely proportional to the lipid packing density. Our results indicate that lipids need not be anionic to
interact with Ab. Electrostatic effects involved in Ab40-lipid interaction are discussed.
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative
disease pathologically characterized by neuroﬁbrillary tan-
gles and neuritic plaques in the brain. Neuroﬁbrillary tangles
are due to hyperphosphorylated tau proteins. Instead of
associating with microtubules, tau proteins aggregate into
insoluble paired helical ﬁlaments when hyperphosphorylated
(Kosik et al., 1986). The neuritic plaques are extracellular
lesions and consist of deposits of amyloid beta (Ab) peptide.
Ab is a 40- to 43-amino acid residue amphiphilic polypeptide
with a hydrophobic C-terminal and a hydrophilic N-terminal
(Hardy, 1997; Selkoe, 1994). During regular cell metabolism,
Ab is cleaved from a transmembrane protein called the
amyloid beta precursor protein (Haass and Selkoe, 1998). The
nonaggregated form of the peptide seems to be a normal
constituent of the cerebrospinal ﬂuid (Seubert et al., 1992).
The classic neuritic plaques contain dense ﬁbrillar deposits of
both Ab40 and Ab42. Amorphous, largely nonﬁbrillar
deposits consisting of solely Ab42 are precursor lesions that
lack damaged neurites (axons and dendrites) (Selkoe, 2000).
Ab42 in several regions of the brain is correlated with the
development of AD and its clinical progression (Naslund
et al., 2000). The secondary structure of the peptide in the
ﬁbrous form is predominantly beta-sheet as demonstrated by
circular dichroism (Barrow et al., 1992; Terzi et al., 1995),
NMR spectroscopy (Coles et al., 1998), and ﬁber x-ray
diffraction (Malinchik et al., 1998). It has been shown by in
vitro cell culture studies that the b-structured aggregates are
toxic to neurons (Lorenzo and Yankner, 1994; Pike et al.,
1993). Whether Ab aggregation in the brain is a cause or
a result ofAD is debated (Hardy, 1997), but evidence seems to
support the former (Selkoe, 2000). Recently, however,
a paradigm shift is emerging as to the nature of the toxic
aggregates. Both in vitro and in vivo studies have revealed
that soluble, oligomeric forms of Ab also have potent
neurotoxic activities. In fact, these may be the proximate
effectors of the neuronal injury and death occurring in AD,
and the disease may be caused not by the mature aggregates
but by the oligomeric intermediates during the aggregation
process itself (Bucciantini et al., 2002; Kirkitadze et al.,
2002). Based on these ﬁndings, it has even been suggested
that Ab can be ‘‘detoxiﬁed’’ by converting the oligomeric
form to the ﬁbrillar form (Lashuel et al., 2002).
Whether the toxic species are mature aggregates or
protoﬁbrils/soluble oligomers, the formation of such entities
requires concentrations of up to millimoles of Ab for short
periods, whereas the in vivo deposition of Ab evolves over
long periods of time by the production of nanomolar
concentrations in the brain. It has been demonstrated that
the presence of lipids can induce the aggregation of Ab atmM
concentrations in similarly short timescales (McLaurin and
Chakrabartty, 1997; Terzi et al., 1997). There have been
suggestions that toxicity of Ab may be due to its interaction
with cell membranes, whereby ion channels are formed,
disrupting the ion equilibria of the cell (Arispe et al., 1993;
Hirakura et al., 1999; Kawahara et al., 1997; Lin et al., 1999;
Volles and Lansbury, 2003) There is also recent evidence that
membrane cholesterol levels may be mediating Ab ﬁbrillo-
genesis (Yip et al., 2001), or that lipid peroxidation may play
a role in the pathogenesis of AD (Koppaka and Axelsen,
2000). Although the exact extent of Ab-membrane in-
teraction remains unclear, all these point to the possible role
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of membrane lipids in Ab oligomerization and aggregation.
There is a general agreement in the literature that electrostatics
plays a role and that Ab interacts with negatively charged
lipids (Bokvist et al., 2004; Chauhan et al., 2000; McLaurin
and Chakrabartty, 1997; Terzi et al., 1994; Vargas et al.,
2000). However, the issue of whether the peptide inserts into
membranes remains unsettled. An understanding of the
interaction between peptidemonomers and lipids is important
in elucidating the mechanism of peptide aggregation/lipid
peroxidation/ion channel formation.
In this article, we address the role of electrostatics on
Ab insertion into model membranes. The hydrophobic
C-terminus of the peptide corresponds to a portion of the trans-
membrane region of the amyloid beta precursor protein. Since
this portion of the peptide is located within the cell membrane
before cleavage, it is plausible that the cleaved peptide inserts
itself back into the membrane, thus anchoring itself at the
membrane surface. The amphipathic nature of the peptide
may also lead to higher local peptide concentrations near the
membrane surface. The proposition that the amyloid peptide
is seeded within the cell membrane and that subsequent oli-
gomerization/ﬁbrillation takes place at the membrane surface
reduces the peptides’ search for each other in three dimensions
to a two-dimensional problem.
Using Langmuir monolayers as model systems, we have
examined the interactions between Ab40 monomers and
various lipids as a function of surface pressures and subphase
conditions. In addition to isothermmeasurements, the surface
morphology of the lipid monolayers was monitored with
ﬂuorescence microscopy (FM). In particular, we have tested
whether anionic lipids are necessary for forming lipid/peptide
complexes. Our results indicate that under physiologically
relevant conditions, Ab inserts into electrically charged lipid
ﬁlms. Even at high surface pressures where the monolayer is
tightly packed and no apparent insertion is detected, we
observe changes in the surface morphology of the lipid ﬁlms.
Our results can be explained by electrostatic arguments.
EXPERIMENTAL PROCEDURES
Materials
The lipids 1,2-dipalmitoylphosphatidylcholine (DPPC), 1,2-dipalmitoyl-
phosphatidylglycerol (DPPG), and 1,2-dipalmitoyl 3-trimethylammonium
propane (DPTAP), the fatty acid-labeled ﬂuorescent dyes N-7-Nitrobenz-2-
oxa-1, 3-diazol-4-yl-phosphatidylcholine (NBD-PC) and N-7- Nitrobenz-2-
oxa-1, 3-diazol-4-yl-phosphatidylglycerol (NBD-PG) were obtained from
Avanti Polar Lipids (Alabaster, AL) in powder form, and used without
further puriﬁcation. The headgroup-labeled ﬂuorescent dye Texas Red 1,2-
dihexadecanoyl 3-phosphoethanolamine (TR-DHPE) was purchased from
Molecular Probes (Eugene, OR). DPPC, DPTAP, NBD-PC, NBD-PG, and
TR-DHPE were dissolved in chloroform (high-performance liquid chroma-
tography grade, Fisher Scientiﬁc); DPPG was dissolved in chloroform with
10% by volume methanol. All lipid stock solutions had a concentration
between 2 and 10 mg/ml. Spreading solutions were prepared by diluting the
stock solutions and adding 0.5mol%of TR-DHPE. The concentrations of the
spreading solutions were between 0.2 and 0.5 mg/ml. Monolayer ﬁlms were
spread using a microsyringe (Hamilton, Reno, NV). All lipid solutions were
stored at 20C in glass vials.
Ab40 was purchased from Anaspec (San Jose, CA) and used without
further puriﬁcation. The molecular mass of the peptide is 4 kD, and it has the
amino acid sequence DAEFRHDSGYEVHHQKLVFFAEDVGSNKG-
AIIGLMVGGVV. Purity was reported to be .95% by high-performance
liquid chromatography. The expected molecular weight was conﬁrmed by
matrix assisted laser desorption/ionization mass spectrometry. Ab40 was
stored at 20C in lyophilized form. To insure that the peptide was in
monomeric form, it was dissolved in dimethyl sulfoxide (DMSO) at least 2 h
before all injection experiments, as this treatment has been reported to
deaggregate any existing multimers and render the peptide monomeric (Shen
and Murphy, 1995). The concentration of peptide in DMSO was 5 mg/ml.
Hexa-ﬂuoro isopropanol, tri-ﬂuoro acetic acid, or tri-ﬂuoro ethanol have also
been reported to ensure a monomeric peptide; however, DMSO is the only
solvent that does not have surface activity. We found that dissolving the
peptide in DMSO is necessary in getting reproducible results.
For dual-probe ﬂuorescence experiments, Ab40 with cysteine substituted
at position 7 was synthesized and then labeled with ﬂuorescein (Choo-Smith
et al., 1997). The tagged peptide was a generous gift from Professor Charles
Glabe of the University of California at Irvine. Five percent ﬂuorescently
labeled peptide was mixed into a peptide solution dissolved in water, and
this mixture was injected into the subphase. All subphases were prepared
using water from a Milli-Q system (Millipore, Bedford, MA). Phosphate-
buffered saline (PBS) subphase at pH 7.4 was prepared with 120 mM NaCl.
Methods
Our experimental setup consists of a custom-made Langmuir trough milled
from a solid piece of virgin Teﬂon (27.53 6.253 0.63 cm) epoxied to a thin
copper plate. The working surface area of the trough is 145 cm2. The
working subphase volume is between 80 ml and 130 ml. Two Teﬂon barriers
are used for symmetric compression with a linear speed of 0.1 mm/s. This
speed corresponds to a typical rate of area change of 102 A˚2/molecules.
Movement of the barriers is achieved by two high-precision translational
stages (UTM100, Newport, Irvine, CA) with a resolution of 1.0 mm; this
translates to a resolution of ;104 A˚2/molecule for a typical experiment.
Compression ratio for the trough from being fully expanded to fully
compressed is 7. Temperature control of the subphase is accomplished using
six thermoelectric cooling elements connected in series (Marlow Industries,
Dallas, TX). These thermoelectric cooling elements are sandwiched between
two copper plates, one to which the trough is mounted and the other
connected to a constant-temperature water bath (Neslab Instruments,
Portsmouth, NH). The subphase temperature is monitored by a submerged
Teﬂon-coated thermistor (Omega Technologies, Stamford, CT). The trough
can be operated in a temperature range of 5–45C. A piece of thin glass
coated with indium tin oxide (Delta Technologies, Dallas, TX), which can be
resistively heated, is placed over the trough to suppress evaporation and
prevent condensation on the microscope objective. The temperature of the
glass is monitored by a thermistor (Omega Technologies) and is typically
maintained slightly above the subphase temperature to minimize convective
currents above the monolayer. A stationary Wilhelmy balance located at the
center of the trough (Riegler and Kirstein, Berlin, Germany) is used to
measure the surface pressure through a hole in the cover-glass.
Fluorescence microscopy
To monitor the surface morphology of the monolayer, a Nikon optical
microscope is positioned above the trough. A 203 or a 503 extra-long
working distance objective can be attached to the microscope. The trough is
mounted on motorized xyz translational stages (Newport, Irvine, CA). The z
axis is for focusing and the x and y axes are for translating the trough to
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observe different regions of the monolayer. A 100-W high-pressure mercury
lamp is used for ﬂuorescence excitation. A dichroic mirror/ﬁlter cube is used
to direct light onto the monolayer and to ﬁlter the emitted ﬂuorescence.
Fluorescence is collected by a silicon intensiﬁed target camera (Hamamatsu,
Bridgewater, NJ). The whole trough/microscope assembly is mounted on
a vibrationally isolated table from Newport. The setup is controlled by
a custom-made graphical interface using LabView (National Instruments,
Austin, TX). Images are recorded with a JVC Super VHS VCR (JVC Co. of
America, Wayne, NJ) and digitized using software from ATI technologies.
Image analysis is performed using Adobe Photoshop software.
Constant pressure assay
Insertion studies using Langmuir monolayers is a sensitive tool for studying
lipid-protein and lipid-peptide interactions (Hanakam et al., 1996). The
method can be employed by keeping the surface area or the surface pressure
constant. We have monitored the interaction of Ab40 with lipids using
a constant surface pressure assay. Surface pressure is deﬁned as the difference
in surface tension between a pure air-ﬂuid interface and one with a monolayer
adsorbed. We have used a lipid monolayer to mimic the outer leaﬂet of
a membrane bilayer. Constant-pressure assays were performed by spreading
a desired lipid onto a subphase free of Ab40 peptide, and then compressing
the lipid ﬁlm to a predetermined surface pressure. This pressurewas chosen to
be between 23 and 30 mN/m for relevance to physiological conditions as the
lipid-packing density of a bilayer is reported to be roughly equal to that of
a monolayer at around 30 mN/m (Seelig, 1987). Once the desired surface
pressure was reached, it was kept constant via a feedback loop built into our
apparatus. Twenty ml of 5 mg/ml Ab40 in DMSO was then aliquoted out,
toppedoffwith 500ml water, and immediately injected into a 90-ml subphase.
To avoid disturbing the lipid ﬁlm, an L-shaped syringe (Hamilton, Reno, NV)
was used for injecting the peptide from underneath one of the barriers. After
peptide injection, the effective relative change in area per lipid molecule
(DA/A)wasmonitored. In this constant-pressuremode, insertionof thepeptide
into the lipid leads to an increase in the lipid surface area. Conversely, the sur-
face area would decrease if the peptide causes the lipid monolayer to dissolve
in the subphase. In all experiments, the average concentration of the peptide in
the total subphase volume after injection was 250 nM and the temperature
of the subphase was 30C. This concentration was well below the critical
micelle concentration of Ab40, which was reported to be around 12.5 mM
(Pike et al., 1993). It should be noted that if the surface area, instead of
the surface pressure, were held constant, peptide insertion into the lipid ﬁlm
would result in an increase in surface pressure.
Three lipids were examined to investigate the effect of headgroup charge
on their ability to interact with Ab peptides: zwitterionic DPPC, anionic
DPPG, and cationic DPTAP. Although saturated lipids are not in abundance
in the cell membrane, these lipids were chosen in our study because they
exhibit a two-phase coexistence region at the temperature and surface
pressures examined, enabling us to perform FM simultaneously with the
isotherm measurements. Half a mole percent TR-DHPE was incorporated
into the spreading solution. The dye molecules are covalently bonded to the
hydrophilic lipid headgroup region. Due to steric reasons, the dye partitions
into the ﬂuid phase, rendering it bright and the condensed phase dark
(Knobler, 1990). To ensure that our results are not artifacts due to the bulky
TR-labeled DHPE molecules interacting with Ab40, we have repeated
ﬂuorescence experiments by replacing TR-DHPE with 1% by mole
ﬂuorescent NBD-PC for DPPC, and 1% by mole NBD-PG for DPPG.
The NBDmoiety is covalently attached to the hydrocarbon tails of the lipids,
thereby diminishing its accessibility to the Ab40 peptide. As TR-DHPE has
a higher quantum yield than NBD, it is necessary to double the mole
percentage from ½ to 1 when switching from TR to NBD to achieve similar
contrast in the micrographs. To ensure that the changes observed with FM
are due to interactions with the peptide and not an artifact of the injection
protocol, we have performed control experiments where blank solution is
injected into the subphase, and it does not alter lipid morphology.
RESULTS
We ﬁrst examined the subphase dependence of the surface
activity of Ab40 and found that the activity of the peptide
increased with increasing ionic strength. Upon injection into
pure water at 30C, Ab40 achieved an equilibrium surface
pressure of 12 mN/m. In PBS subphase, the surface pressure
was 15mN/m. Increasing saline concentration of the buffered
subphase from 120 mM to 240 mM increased Ab40 surface
activity further, resulting in a surface pressure of 17 mN/m
(Fig. 1). The timescale for Ab40 surface adsorption is also
dependent on the subphase conditions. Surface pressure
proﬁle upon Ab40 injection changes from a sigmoidal rise in
water subphase to an asymptotically increasing one in PBS.
We have carried out constant-pressure measurements with
DPPG, DPPC, and DPTAP monolayers under different
surface pressure and subphase conditions. The total relative
change in area (DA/A), obtained after reaching a steady-state
plateau (typically between 1.5 and 5 h after Ab40 injection)
are summarized in Table 1 as a function of surface pressure,
lipid identity, and subphase conditions. Although cationic
lipids are not found under physiological conditions, zwitter-
ionic DPPC, anionic DPPG, and cationic DPTAP were
chosen to provide a full spectrum in examining the role of
headgroup electrostatics on the interaction of Ab40 with
lipids. Table 1 clearly indicates that Ab40 inserts much more
readily into DPPG andDPTAPmonolayers than DPPC under
similar conditions in both pure water and PBS subphase.
For a typical constant-pressure experiment, the lipid
monolayer was spread at the interface with a high surface
area per molecule to ensure the ﬁlm remains at gas-liquid
phase coexistence, thus guaranteeing the formation of a
homogeneous ﬁlm. Compression of the ﬁlm did not occur
until at least 5 min after the initial spread to allow for solvent
FIGURE 1 Change in surface pressure as a function of time upon
injection of Ab40 into different subphases: (s) water, (n) pH¼7.4
phosphate buffer, (n) phosphate buffer with 120 mM NaCl, and (3)
phosphate buffer with 240 mM NaCl. The time of injection is taken as t¼ 0.
The concentration of Ab in the subphase is 250 nM, and the subphase
temperature is 30C.
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evaporation. Fig. 2 A shows the pressure area isotherm
of a DPPG ﬁlm spread at ;118 A˚2/molecule on pure water.
The DPPG ﬁlmwas compressed to 25 mN/m (indicated by an
arrow in Fig. 2 A), after which the pressure was held constant.
Ab was then injected into the subphase. The area per DPPG
molecule was 45 A˚2 at the time of peptide injection. This point
is marked with an arrow in the ﬁgure. Subsequent insertion of
Ab40 resulted in an increase in the surface area. Fig. 2 B
shows the corresponding relative change in area per molecule
after peptide injection as a function of time. The moment of
peptide injection was taken to be t ¼ 0. Within 2 h after
injection, the effective area per lipid molecule reached
;92 A˚2. The change is roughly 105%, as shown in Fig. 2 B.
The morphological changes of the DPPG monolayer
resulting from Ab40 injection are shown in Fig. 3. Fig. 3 A
shows the FM image of the DPPG monolayer at 25 mN/m
before the injection of Ab into the subphase. The ordered
condensed phase is dark since the dye is excluded from the
ordered domains due to steric hindrance. The less ordered
phase, termed liquid-expanded phase, is bright as a result of
dye partitioning. As clearly demonstrated by the image (Fig.
3 A), most of the DPPG ﬁlm is in the condensed phase at
25 mN/m under the given experimental conditions. Fifteen
min after injection of peptide (Fig. 3 B), the ratio of dark to
bright regions is reduced. The reduction becomes more pro-
nounced with time (Fig. 3C) as Ab disrupts lipid packing and
decreases the size of the dark ordered condensed domains
while increasing that of the disordered phase. The peptide
also induces fuzziness at domain boundaries, suggesting that
the phase boundaries could be the preferred locations for pep-
tide insertion. At 150 min after injection (Fig. 3 D), the bound-
ary between the ordered and disordered regions became less
sharp with the emergence of a gray phase. Insertion into
DPPG monolayers at 30 mN/m shows similar trends,
resulting in both area increase and morphological changes
(data not shown), though to a lesser extent (Table 1).
For a DPTAP monolayer at 25 mN/m on pure water, the
change in total area is 89% after the injection of Ab. Fig. 4 A
shows the corresponding progression in the surface morphol-
TABLE 1 Percentage change in lipid area upon Ab insertion
Pressure Pure water PBS
DPPC 23 mN/m 4
Dipole-
dipole
6
Ion-
dipole
25 mN/m ,2 2
30 mN/m - -
DPPG 23 mN/m 140
Ion-
dipole
13
Ion-ion
(repulsive)
25 mN/m 108 10
30 mN/m 14 ,2
DPTAP 23 mN/m 144
Ion-
dipole
79
Ion-ion
(attractive)
25 mN/m 89 34
30 mN/m 35 4
Percentage area change as Ab peptides insert into lipid monolayers as
a function of lipid identity, surface pressure, and two different subphase
conditions. The concentration of Ab in the subphase is 250 nM, and T ¼
30C for all experiments. The nature of the electrostatic interaction between
the lipid and the peptide is also indicated. The calculated net charge of Ab
is 0 in pure water (pH 5.5), and 3 in PBS (pH 7.4).
FIGURE 2 (A) Isotherm showing the increase in area per DPPG molecule
upon Ab40 injection at a constant surface pressure of 25 mN/m. The arrow
marks the time of peptide injection. (B) The corresponding percentage
change in area per molecule as a function of time upon injection. Time zero
corresponds to the moment of peptide injection. Temperature is 30C and
subphase is pure water.
FIGURE 3. Domain morphology of a DPPG monolayer on a water
subphase at 30C and a constant surface pressure of 25 mN/m. Images were
taken (A) before, (B) 15 min after, (C) 45 min after, and (D) 2.5 h after
injection of peptide. The scale bar is 100 mm.
Insertion of Ab40 into Lipid Monolayers 1735
Biophysical Journal 87(3) 1732–1740
ogy of the monolayer. By 4 h after Ab injection (Fig. 4 A4),
the surface morphology shows no resemblance to that before
peptide injection (Fig. 4 A1). The peptide initially causes the
dark condensed-phase domains to coalesce (Fig. 4 A2) and
thereafter signiﬁcantly reduces the amount of condensed-
phase domains. The morphological changes are just as
prominent at 30 mN/m, and the decrease in condensed to
ﬂuid lipid area fraction is apparent (Fig. 4 B). On a PBS at
30 mN/m, the condensed-phase domains are reduced in size
(Fig. 4 C) but not as drastically as for the same pressure in
pure water (Fig. 4 B). Even 2 h after peptide injection, re-
sidual condensed domains are still discernable (Fig. 4 C4).
In the case of DPPC, the amount of insertion is much less
compared to DPPG or DPTAP in both water and PBS.
Nevertheless, at 23 mN/m in PBS, a 6% area change
is accompanied by a visible decrease in the amount of
condensed-phase domains (Fig. 5 A). Even under conditions
where there is no signiﬁcant change in the area after Ab40 is
injected into the subphase (e.g., at 30 mN/m), we observe
signiﬁcant changes in the shape and distribution of the
domains. Fig. 5 B shows how the condensed-phase domains
of DPPC on a water subphase at a surface pressure of 25 mN/
m abandon their discrete domain structure and coalesce upon
Ab injection. In this case, the recorded area change is ,2%
(Table 1). Although the amount of increase in insertion going
from water to PBS is small, the difference is statistically
signiﬁcant and if the salt concentration is increased to 240
mM NaCl, the amount of insertion at 25 mN/m goes up to
7% (Fig. 6).
To identify the location of the peptide in the lipidmatrix, we
have carried out dual probe ﬂuorescence measurements.
Fluorescein-labeled peptides were used to insert into
TR-labeled lipids at a surface pressure of 30 mN/m for DPPG
andDPTAP. The images shown are for a pure water subphase
for DPPG and PBS subphase for DPTAP (Fig. 7).
Fluorescence images were obtained for the two different
emission wavelengths by switching the ﬁlter cubes to
FIGURE 4 Domain morphology of a DPTAP monolayer on a water subphase at a constant surface pressure of (A) 25 and (B) 30 mN/m, and (C) on PBS
subphase at 30 mN/m. Images were taken (1) before injection, (2) right after injection, (3) 45–60 min after injection, and (4) 2–4 h after injection. For all cases,
temperature is 30C, Ab40 concentration in the subphase is 250 nM, and the scale bar is 100 mm. The fringes extending from the domains in B1 are due to an
instability of the condensed DPTAP domain shape under the given experimental conditions, and can also be seen for DPPC in Fig. 5 A1 (Diamant et al., 2001).
FIGURE 5 Domain morphology of a DPPC monolayer (A) on a PBS
subphase at a constant surface pressure of 23 mN/m; and (B) on a pure water
subphase at 25 mN/m. Images were taken (1) before and (2) 10 min or 2 h
after injection for the PBS (A2) and water (B2) subphases, respectively. The
scale bar is 100 mm.
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correlate the location of the peptide with the phase of the lipid
monolayer. For DPPG monolayers, the peptide inserts
preferentially into the disordered region of the ﬁlm, as
indicated by the correspondence between the bright and gray
phases in the ﬂuorescence micrograph showing the tagged
lipid (Fig. 7 A) and the bright phase in that for the tagged
peptide (Fig.7 B). Preference for the disordered region of the
monolayer is also found for DPPC on PBS subphase (data not
shown). In the case of DPTAP, however, ﬂuorescence from
the peptide is uniform in the monolayer, and no preference for
the disordered region is found (Fig. 7, C and D).
DISCUSSION
To understand the role of membrane lipids in mediating the
behavior of Ab peptides, we have examined the interaction
between model lipid membranes and monomeric Ab
peptides. Our membrane model is an approximation to the
outer leaﬂet of the cellmembrane.Although cationic lipids are
not present in human cell membrane, using DPTAP is critical
to understand the role of charge on peptide adsorption. The
interaction between Ab and phospholipids has been in-
vestigated previously with mixed conclusions regarding the
insertion of the peptide into membranes. Results from vesicle
rupture/dye release experiments (McLaurin and Chakra-
bartty, 1997) support insertion under physiological conditions
whereas monolayer experiments (Terzi et al., 1997) demon-
strate otherwise. Other results suggest there may be two
different modes of interaction where the peptide may be ad-
sorbed onto or inserted intomembranes (Bokvist et al., 2004).
There is, nonetheless, a general agreement that Ab prefers to
bind to negatively charged or acidic phospholipids. Alterna-
tively, our results demonstrate that cationic lipids can interact
with Ab just as strongly as anionic lipids, which are in
agreement with a recent report by Kremer et al. (2001).
Constant-pressure assays show that the level of change in
the effective area occupied by a phospholipid molecule after
the introduction of Ab peptides into the subphase is a function
of subphase conditions, as well as pressure and identity of the
lipid monolayer employed. In the pure water case, we have
observed a signiﬁcantly higher level of insertion for the
peptide into the charged lipid monolayers of DPTAP and
DPPG as opposed to the zwitterionic DPPC ﬁlms. This can be
understood in terms of the ion-dipole interaction between the
lipid and the peptide in the former case and the weaker dipole-
dipole interaction in the latter case when the subphase used is
pure water (Table 1).
In PBS, the level of insertion of the peptide into charged
lipid monolayers is still higher than that observed in
zwitterionic ﬁlms, with the greatest insertion observed with
DPTAP. When the subphase condition changes from pH 5.5
(pure water) to pH 7.4 (PBS), the three histidine residues turn
from positively charged to neutral by losing a proton, leaving
the peptide with a net negative charge (although surface pH
may be slightly lower than bulk pH, the effect is not large
enough to lower the pH to the isoelectric point of the peptide
(Bostrom et al., 2002)). It is therefore logical for the peptide to
interact more favorably with the positively charged DPTAP
monolayers compared to the zwitterionic DPPC or anionic
DPPG monolayers. It should be noted that there is still sub-
stantial insertion of the negative peptide into anionic DPPG
monolayers, despite the fact that both have similar charges.
This can be accounted for by the fact that whereas the pep-
tide has an overall negative charge, there remain positively
charged residues that can interact favorably with the anionic
DPPGmolecules. Nonetheless, the overall negative charge on
the peptide substantially reduces the level of insertion into
FIGURE 6 The percentage change in area per DPPC molecule as
a function of subphase conditions upon injection of Ab40 at a constant
surface pressure of 25 mN/m. Time zero corresponds to the moment of
peptide injection. Subphase temperature is 30C.
FIGURE 7 Dual probe ﬂuorescence micrographs of (A and B) DPPG and
(C and D) DPTAP show the different modes of interaction with Ab40. Left
panels show ﬂuorescence from the emission of Texas-Red dye tagged to the
lipid; right panels show that of ﬂuorescein tagged to Ab40. The DPPG ﬁlm
was at 30 mN/m on a pure water subphase and the DPTAP ﬁlm was at
30 mN/m on PBS. Both experiments were performed at 30C. The scale bar
is 100 mm.
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DPPG as compared to DPTAP under buffered saline
conditions.
In comparing the effect of subphase conditions, we note
that the propensity of the peptide to adsorb to the air-water
interface increases in PBS compared to pure water (Fig. 1). In
water the peptide monomers can be approximated as dipoles,
and these dipoles have a characteristic packing at the air-water
interface. In PBS the peptide has an overall charge of3. The
interaction between the charged peptides in the presence of
screening salt becomes equivalent to the one between dipoles
because of the oppositely charged cloud of counter ions. Thus,
as the subphase salt concentration is increased with sub-
sequent decrease in the screening length, one may be able to
reach a regimewhere the effective dipolemoments areweaker
than the real dipole of the peptide in pure water (Andelman
et al., 1987). One therefore expects that with everything else
held constant, the amount of insertion should increase going
from pure water to PBS. However, this effect is observed only
in the case of DPPC. For DPPG, the effect is offset by the
electrostatic repulsion with the peptide, as explained above.
What is puzzling is the case for DPTAP. Ab40 inserts much
more readily intoDPTAP inpurewater than in buffered saline.
As mentioned earlier, the peptide is neutral in pure water but
carries an overall negative charge in buffered saline. With
both pH and ionic strength effects pointing to an increase in
insertion in PBS, why then would a peptide insert less into
a cationic lipid ﬁlmwhen it is in an anionic state as opposed to
a zwitterionic state? The answer, we propose, lies in the strong
electrostatic interaction between the cationic lipid headgroup
and the anionic peptide. This interaction is so dominant that
the peptide is strongly attracted and trapped in the headgroup
area instead.
To check this hypothesis, we have carried out dual-probe
experiments in which ﬂuorescein-labeled peptides were used
to insert into TR-labeled lipids. These experiments clearly
indicate that in PBS subphase, Ab40 does not differentiate
between condensed versus ﬂuid regions but adsorbs uni-
formly onto theDPTAP ﬁlm. This result is consistent with our
hypothesis that the attractive electrostatic interaction between
DPTAP and Ab40 overwhelms the additional gain in energy
resulting from the insertion of Ab40 into the lipid ﬁlm. To
further substantiate our hypothesis and obtain a quantitative
picture of where and how Ab lies on the membrane surface,
we are studying the effect of Ab40 on DPPC, DPPG, and
DPTAP using grazing-incidence x-ray diffraction, x-ray
reﬂectivity, and neutron reﬂectivity.
For all surface pressures where there is insertion we detect
via FM that Ab disrupts the ordered phase of the lipids. This
is true even under conditions where we see minimal (Fig. 5
B) or no insertion (data not shown), indicating that Ab
causes surface reorganization of the lipids. We observe that
when there is insertion, the boundary between the ordered
and disordered regions becomes fuzzy, suggesting that the
phase boundaries could be the preferred locations for the
peptide. However, this does not imply that a two-phase
coexistence of the lipids is necessary for peptide insertion. In
fact, we have observed insertion of the peptide into single-
phase ﬁlms formed by unsaturated phospholipids under
similar experimental conditions (data not shown).
It should be pointed out again that the electrostatic effects
on peptide insertion have two contributing factors: the over-
all change in peptide charge due to pH adjustments, and the
alterations in screening length due to changes in ionic strength.
In this article, comparisons are drawn between peptide
insertion into lipid ﬁlms on a pure water subphase and that
with a buffered saline subphase, whereby both the pH and the
ionic strength are altered simultaneously. Although it is
difﬁcult to decouple the effects of pH from those of ionic
strength with only the data presented here, one should be able
to do so if one parameter is changed at a time. This should also
enable one to determine which factor is dominant. Indeed we
have performed another set of insertion experiments at pH 7.4
phosphate buffer with no additional salt (data not shown).
Under this subphase condition, we have observed a slight
increase in insertion in DPPC but a decrease in both DPPG
andDPTAPwhencompared to results at pH5.5. Such changes
in the insertion proﬁles for all three lipids are qualitatively
similar to those observed at pH 7.4 with 120 mM NaCl.
Hence, changes in the overall peptide charge brought about
by adjusting the pH play a more dominant role than changes
due to the ionic strength in determining the level of peptide
insertion. The addition of 120 mM NaCl to the pH 7.4
subphase merely results in an increase in the level of insertion
for all three lipids. In fact, the increase in insertion for both
DPPG and DPTAP is small enough to be offset by the
decrease resulting from peptide charge effects due to pH
change, whereas for DPPC, both effects are in the same
direction, resulting in an overall increase in insertion. These
observations suggest that an increase in the ionic strength of
the subphase leads to a corresponding increase in the peptide’s
propensity to associate with the interface.We have carried out
experiments at an even higher salt concentration of 240 mM
NaCl and have observed that this trend continues to persist.
For pure peptide adsorption, we have shown in Fig. 1 that the
surface activity of the peptide increases with ionic strength.
For peptide insertion into a lipid ﬁlm, Fig. 6 demonstrates that
the level of insertion is further enhanced when the ionic
strength is changed from 120 mM to 240mM. Since both sets
of experiments were performed at constant pH, the observed
changes can only be attributed to the increased ionic strength,
which seems to produce an enhanced hydrophobic effect.
Although electrostatics is likely to play a major role in
determining the level of insertion, there can be other factors
that contribute to the phenomena observed. One plausible
factor is the head-tailmismatch of the lipids. The tail groups of
the three lipids studied are identical, but the headgroups are
different. DPPC has a larger headgroup than both DPPG and
DPTAP. DPPG molecules are able to tightly pack with the
tails arranged in a hexagonal fashion at high surface pressure;
DPTAP, and to a greater extent DPPC, cannot pack as tightly
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due to a head-tail mismatch, causing their tailgroups to be
tilted even at high surface pressures (Ege, 2004). On this basis
alone, one would expect insertion to favor DPPC over
DPTAP and DPPG in the given order. Our measurements,
however, indicate otherwise, leading us to conclude that the
head-tail mismatch is not a signiﬁcant factor in determining
peptide insertion. Experiments are currently underway to
explore the effect of unsaturation in the tailgroup on peptide
insertion.
In a recent article, Bokvist et al. (2004) discuss a model
where Ab40 interacts with mixed DMPC/DMPG vesicles
(where DMPC and DMPG have headgroups identical to
DPPC and DPPG, respectively, but have hydrocarbon tails
that are 14 carbons long instead of 16). They differentiate
between two modes of interaction: where the peptide, when
added into a vesicle solution, is adsorbed on the surface of
the vesicles and causes aggregation; or where, when the
vesicles are prepared with peptide present, the peptide is
inserted and bound to the vesicles and is stable so that no
aggregation occurs. Our experimental results for DPPG in
PBS show that Ab40 does not insert to an appreciable extent
into DPPG at packing densities relevant to that found in
vesicles. Though the insertion assay used cannot detect if
Ab40 is adsorbed underneath the monolayer, FM shows that
DPPG morphology changes even though insertion is minor
(a similar morphological change of DPPC at conditions of
low peptide insertion is seen in Fig. 5 B). The change in
morphology of the monolayer suggests that the peptide is
associated with the lipid surface, consistent with the ﬁndings
of Bokvist et al. (2004).
The electrostatic explanation we propose does not consider
the detailed structure of the peptide but treats it as a large ion
(or a dipole in the case of water subphase). The argument
given thus accounts for the ability of the peptide to ﬁnd the
membrane surface. Insertion into the membrane, however, is
motivated by the stabilization of the hydrophobic tail of
Ab40. For this reason, the longer version of the peptide,
Ab42,with the additional residues isoleucine and alanine, can
be predicted to insert into membranes to a greater extent. The
extent of insertion can be quantiﬁed by x-ray reﬂectivity mea-
surements that are currently underway. The additional hydro-
phobic residues also make Ab42 more prone to aggregation.
Finally, we would like to brieﬂy discuss the issue of
oligomerization and how it may contribute to the observed
differences in peptide insertion. The oligomeric form of
the peptide has been receiving increased attention as the
speculated culprit of AD. We have preliminary evidence
suggesting that the oligomeric form of the peptide (obtained
by aging peptide monomers in water) inserts to a greater
extent into lipid ﬁlms compared to its monomeric counter-
part. Although the insertion results in Table 1 do not contain
information on the kinetics of insertion, some of the ﬁgures
presented show the time course of surface adsorption of the
peptide (Fig. 1) and peptide insertion into lipid ﬁlms (Figs. 2
B and 6). These ﬁgures capture the differences in insertion
kinetics for water subphase versus PBS. It is obvious from
Fig. 1 that the lag time for surface association found in water
is greatly reduced and eventually eliminated with increased
ionic strength. As already discussed, increases in ionic
strength seem to enhance the hydrophobicity of the peptide,
which can be stabilized by peptide insertion into the lipid
ﬁlm and/or lipid oligomerization. Since both mechanisms
would result in accelerated surface association, both could
contribute to the observed decrease in lag time.
Since the formation of soluble, toxic oligomers has been
proposed to be a key pathogenic process in AD (Bucciantini
et al., 2002), an understanding of the interaction of Ab with
membranes becomes more valuable as it pertains to the
toxicity mechanism. It is clear that under conditions where
Ab40 can insert into membranes extensively, the alteration
to the membrane is considerable, possibly to the extent of
affecting its proper functioning. A relevant issue that arises
from our work is to distinguish between monomeric species
versus oligomeric species inserting into the membrane. Two
possibilities are that peptide inserts as a monomer and
transposes its environment to initiate aggregation into
oligomers/protoﬁbrils or that the peptide oligomerizes and
then inserts into membranes to stabilize itself. Studies are
underway to examine these two possible scenarios.
A clear trend from our results is the decrease in insertion
with corresponding increase in surface pressure for all three
lipids. This is not surprising: at high surface pressures where
the hydrocarbon chains of the lipids are tightly packed, the
peptide cannot insert easily. However, one can envision that
the peptide can readily insert into damaged cells where the
membrane integrity is compromised, or if negatively charged
lipids of the inner leaﬂet of the cell membrane are somehow
exposed to the extracellular region. In this context, it is
worthwhile to take into account the effect of aging or damage
(e.g., oxidative damage) on cell membrane function when
discussing AD.
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